188 related articles for article (PubMed ID: 26118618)
1. Long-term survival after curative resection for pancreatic ductal adenocarcinoma--Surgical treatment.
Benassai G; Quarto G; Perrotta S; Furino E; Benassai GL; Amato B; Bianco T; De Palma G; Forestieri P
Int J Surg; 2015 Sep; 21 Suppl 1():S1-3. PubMed ID: 26118618
[TBL] [Abstract][Full Text] [Related]
2. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
4. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
Zacharias T; Jaeck D; Oussoultzoglou E; Neuville A; Bachellier P
J Gastrointest Surg; 2007 Mar; 11(3):350-6. PubMed ID: 17458610
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
7. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
8. Survival following curative resection for pancreatic ductal adenocarcinoma. A systematic review of the literature.
Garcea G; Dennison AR; Pattenden CJ; Neal CP; Sutton CD; Berry DP
JOP; 2008 Mar; 9(2):99-132. PubMed ID: 18326920
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
11. Predicting survival after surgical resection for pancreatic ductal adenocarcinoma.
Moon HJ; An JY; Heo JS; Choi SH; Joh JW; Kim YI
Pancreas; 2006 Jan; 32(1):37-43. PubMed ID: 16340742
[TBL] [Abstract][Full Text] [Related]
12. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience.
Takai S; Satoi S; Toyokawa H; Yanagimoto H; Sugimoto N; Tsuji K; Araki H; Matsui Y; Imamura A; Kwon AH; Kamiyama Y
Pancreas; 2003 Apr; 26(3):243-9. PubMed ID: 12657950
[TBL] [Abstract][Full Text] [Related]
15. Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.
Meyer W; Jurowich C; Reichel M; Steinhäuser B; Wünsch PH; Gebhardt C
Surg Today; 2000; 30(7):582-7. PubMed ID: 10930222
[TBL] [Abstract][Full Text] [Related]
16. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
17. Oncological outcome of laparoscopically assisted pancreatoduodenectomy for ductal adenocarcinoma in a retrospective cohort study.
Kuesters S; Chikhladze S; Makowiec F; Sick O; Fichtner-Feigl S; Hopt UT; Wittel UA
Int J Surg; 2018 Jul; 55():162-166. PubMed ID: 29807171
[TBL] [Abstract][Full Text] [Related]
18. [Surgery for pancreatic cancer].
Welsch T; Büchler MW; Schmidt J
Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
[TBL] [Abstract][Full Text] [Related]
19. Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas.
Åkerberg D; Ansari D; Andersson R
World J Gastroenterol; 2016 Jul; 22(28):6424-33. PubMed ID: 27605878
[TBL] [Abstract][Full Text] [Related]
20. [Long-term results after radical resections for pancreatic ductal adenocarcinoma--10 years experience].
Krejcí T; Leffler J; Poloucek P
Rozhl Chir; 2007 Apr; 86(4):174-9. PubMed ID: 17626458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
